Scalp Cooling in MBC
A phase 2 trial of Scalp cooling in Breast cancer, run by Dana-Farber Cancer Institute, now recruiting.
Overview
Scalp Cooling in MBC is a phase 2 interventional study registered as NCT04986579 by Dana-Farber Cancer Institute, with 120 participants planned, started 2021-10-07 and due to reach its primary completion in 2028-06-01. Interventions recorded: Paxman Scalp Cooling System, Eribulin, Sacituzumab govitecan, Trastuzumab deruxtecan. Conditions recorded: Metastatic Breast Cancer, Chemotherapy-induced Alopecia.
Linked to the technology Scalp cooling because the registry names it ("scalp cooling") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types) and the tag pipeline.
- TrialAsian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
Shares Eribulin, Sacituzumab govitecan and the tag pipeline.
- TrialSYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Shares Eribulin, Breast cancer (all types) and the tag pipeline.
- TrialA Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer
Shares Eribulin and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.